These preclinical data support the use of rAAV2-IL-15-infected microglia as a tool to vehicle and translate the EE signals inside the tumor mass and offer a new perspective to use them as Trojan horses to modify the tumor microenvironment. The gene discussed is IL15; the disease is neoplasm.